Mind Medicine (MNMD) Misses Q2 EPS by 23c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.76), $0.23 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Kite Realty sells City Center in White Plains for $50 million